In vitro protection of adipose tissue-derived mesenchymal stem cells by erythropoietin

Acta Histochemica

Volumn 116, Issue 1, 2014, Pages 117-125

  Ercan, Ertugrul ^a   Bagla, Aysel Guven ^b   Aksoy, Ayca ^c   Gacar, Gulcin ^c   Unal, Z Seda ^c   Asgun, H Fatih ^b   Karaoz, Erdal ^c  

^a IZMIR UNIVERSITY   (Turkey)

^b ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

^c KOCAELI UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Erythropoietin; Erythropoietin receptor; Human adipose tissue; Stem cell

Indexed keywords

CASPASE 3; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HYDROGEN PEROXIDE; RECOMBINANT ERYTHROPOIETIN; CASP3 PROTEIN, HUMAN; EPO PROTEIN, HUMAN; OXIDIZING AGENT; TELOMERASE; TRANSCRIPTOME;

ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE; ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELL; ADULT; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DAMAGE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; ISCHEMIA; MESENCHYMAL STEM CELL; PROTEIN EXPRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; SUBCUTANEOUS FAT;

APOPTOSIS; CASPASE 3; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYTOPROTECTION; ERYTHROPOIETIN; HUMANS; HYDROGEN PEROXIDE; MESENCHYMAL STROMAL CELLS; OXIDANTS; OXIDATIVE STRESS; SUBCUTANEOUS FAT; TELOMERASE; TRANSCRIPTOME;

EID: 84893402773     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2013.06.007     Document Type: Article

References (33)

1. Antonitsis P., Ioannidou-Papagiannaki E., Kaidoglou A., Papakonstantinou C. In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells. The role of 5-azacytidine. Interact Cardiovasc Thorac Surg 2007, 6:593-597.
2. Calvillo L., Latini R., Kajstura J., Leri A., Anversa P., Ghezzi P., et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci USA 2003, 100:4802-4806.
3. Fandrey J., Frede S., Jelkmann W. Role of hydrogen peroxide in hypoxia-induced erythropoietin production. Biochem J 1994, 303:507-510.
4. Fiordaliso F., Chimenti S., Staszewsky L., Bai A., Carlo E., Cuccovillo I., et al. A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury. Proc Natl Acad Sci USA 2005, 102:2046-2051.
5. George J., Goldstein E., Abashidze A., Wexler D., Hamed S., Shmilovich H., et al. Erythropoietin promotes endothelial progenitor cell proliferative and adhesive properties in a PI 3-kinase-dependent manner. Cardiovasc Res 2005, 68:299-306.
6. Hwangbo S., Kim J., Her S., Cho H., Lee J. Therapeutic potential of human adipose stem cells in a rat myocardial infarction model. Yonsei Med J 2010, 51:69-76.
7. Jiang B., Liang P., Zhang B., Huang X., Xiao X. Enhancement of PPAR-beta activity by repetitive low-grade H(2)O(2) stress protects human umbilical vein endothelial cells from subsequent oxidative stress-induced apoptosis. Free Radic Biol Med 2009, 46:555-563.
8. Jiang B., Liang P., Zhang B., Song J., Huang X., Xiao X. Role of PPAR-beta in hydrogen peroxide-induced apoptosis in human umbilical vein endothelial cells. Atherosclerosis 2009, 204:353-358.
9. Jing D., Parikh A., Canty J.M., Tzanakakis E.S. Stem cells for heart cell therapies. Tissue Eng Part B Rev 2008, 14:393-406.
10. Karaoz E., Doǧan B.N., Aksoy A., Gacar G., Akyüz S., Ayhan S., et al. Isolation and in vitro characterisation of dental pulp stem cells from natal teeth. Histochem Cell Biol 2010, 133:95-112.
11. Kim Y.A., Lim S.Y., Rhee S.H., Park K.Y., Kim C.H., Choi B.T., et al. Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in betaamyloid-treated C6 glioma cells. Int J Mol Med 2006, 17:1069-1075.
12. Kimura T., Sonoda Y., Iwai N., Satoh M., Yamaguchi-Tsukio M., Izui T., et al. Proliferation and cell death of embryonic primitive erythrocytes. Exp Hematol 2000, 28:635-641.
13. Leri A., Kajstura J., Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 2005, 85:1373-1416.
14. Li Y., Takemura G., Okada H., Miyata S., Maruyama R., Li L., et al. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Cardiovasc Res 2006, 71:684-694.
15. Liao R., Pfister O., Jain M., Mouquet F. The bone marrow - cardiac axis of myocardial regeneration. Prog Cardiovasc Dis 2007, 50:18-30.
16. Madonna R., De Caterina R. Adipose tissue: a new source for cardiovascular repair. J Cardiovasc Med (Hagerstown) 2010, 11:71-80.
17. Marzo F., Lavorgna A., Coluzzi G., Santucci E., Tarantino F., Rio T., et al. Erythropoietin in heart and vessels: focus on transcription and signalling pathways. J Thromb Thrombolysis 2008, 26:183-187.
18. Mazo M., Arana M., Pelacho B., Prosper F. Mesenchymal stem cells and cardiovascular disease: a bench to bedside roadmap. Stem Cells Int 2012, [Epub 2012 January 22]. 10.1155/2012/175979.
19. Moon C., Krawczyk M., Ahn D., Ahmet I., Paik D., Lakatta E.G., et al. Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc Natl Acad Sci USA 2003, 100:11612-11617.
20. Muscari C., Bonafé F., Carboni M., Govoni M., Stanic I., Gamberini C., et al. Difluoromethylornithine stimulates early cardiac commitment of mesenchymal stem cells in a model of mixed culture with cardiomyocytes. J Cell Biochem 2008, 103:1046-1052.
21. Parsa C.J., Matsumoto A., Kim J., Riel R.U., Pascal L.S., Walton G.B., et al. A novel protective effect of erythropoietin in the infracted heart. J Clin Invest 2003, 112:999-1007.
22. Pasha Z., Wang Y., Sheikh R., Zhang D., Zhao T., Ashraf M. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 2008, 77:134-142.
23. Passier R., Mummery C. Cardiomyocyte differentiation from embryonic and adult stem cells. Curr Opin Biotechnol 2005, 16:498-502.
24. Peng L., Yan C., Wu X., Nie L. Comparability of the results of PT-INR with local MNPT and APTTR with MNAPTT on different coagulation analyzers in China. Int J Lab Hematol 2009, 31:352-358.
25. Rangappa S., Entwistle J.W., Wechsler A.S., Kresh J.Y. Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype. J Thorac Cardiovasc Surg 2003, 126:124-132.
26. Robey T.E., Saiget M.K., Reinecke H., Murry C.E. Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 2008, 45:567-581.
27. Sachinidis A., Kolossov E., Fleischmann B.K., Hescheler J. Generation of cardiomyocytes from embryonic stem cells experimental studies. Herz 2002, 27:589-597.
28. Sterin-Borda L., Barcelo A.C., Bozzini C.E. Erythropoietin improves cardiac contractility in post-hypoxic mice. Br J Haematol 2003, 121:180-186.
29. Ueba H., Brines M., Yamin M., Umemoto T., Ako J., Momomura S., et al. Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietin. Proc Natl Acad Sci USA 2010, 107:14357-14362.
30. Uemura R., Xu M., Ahmad N., Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 2006, 98:1414-1421.
31. van der Meer P., Lipsic E., Henning R.H., de Boer R.A., Suurmeijer A.J., van Veldhuisen D.J., et al. Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury. Eur J Heart Fail 2004, 6:853-859.
32. Van Laake L.W., Van Hoof D., Mummery C.L. Cardiomyocytes derived from stem cells. Ann Med 2005, 37:499-512.
33. Xie X.J., Wang J.A., Cao J., Zhang X. Differentiation of bone marrow mesenchymal stem cells induced by myocardial medium under hypoxic conditions. Acta Pharmacol Sin 2006, 27:1153-1158.